当前治疗和关于恶性瘤ROS1向治疗的新见解
Shizhe Li1, He Zhang1, Ting Chen1
1Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Cancer medicine
|April 17, 2024
概括
ROS1抑制剂在治疗NSCLC等癌症方面表现有前途,但仍然存在挑战. 需要进一步的研究,以了解不良影响,耐药性机制,并优化下一代疗法,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- ROS1原瘤基因编码了一种涉及各种恶性瘤的氨酸激酶.
- 已批准的ROS1抑制剂用于NSCLC,但耐药性和副作用令人担忧.
- 下一代ROS1抑制剂正在对中枢神经系统转移和抵抗进行试验,但需要进一步研究.
研究的目的:
- 系统地审查ROS1抑制剂的生物机制和临床应用.
- 分析ROS1向治疗的研究进展和未来前景.
- 确定有关ROS1抑制剂的不良影响和耐药性机制的知识差距.
主要方法:
- 系统地在文献中搜索有关ROS1及其抑制剂的最新文章.
- 对生物机制,诊断方法和临床应用进行审查.
- 分析目前的研究进展和ROS1向治疗的未来方向.
主要成果:
- 在恶性瘤中,ROS1的表达很高,对NSCLC有有限的批准抑制剂.
- 现有的ROS1抑制剂在其他癌症中的有效性尚未完全确定.
- 下一代抑制剂可能会克服抗性和中枢神经系统转移,但会增加副作用.
结论:
- 对下一代ROS1抑制剂的进一步研究至关重要,重点是药物向相互作用和组合疗法.
- 了解ROS1局部化,融合伙伴和药物结合部位是必不可少的.
- 需要进行临床研究来评估ROS1抑制剂,化疗和免疫治疗之间的相关性.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
